Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extreme Hodgkin's lymphoma: current problem areas.

S J Proctor1, J Wilkinson

  • 1Department of Haematological Oncology, University of Newcastle-upon-Tyne, UK. S.J.Proctor@newcastle.ac.uk

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|May 17, 2006
PubMed
Summary

Risk-based therapy and web-based data collection are improving outcomes for Hodgkin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SWAT 116: the effectiveness of an infographic to improve trial recruitment-a randomised study within a trial (SWAT).

Trials·2026
Same author

SWAT 119: the effectiveness of a Thank You card to improve trial follow-up; a randomised study within a trial (SWAT).

Trials·2026
Same author

Long-Range Transverse-Momentum Correlations and Radial Flow in Pb-Pb Collisions at the LHC.

Physical review letters·2026
Same author

Search for Quasiparticle Scattering in the Quark-Gluon Plasma with Jet Splittings in pp and Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2025
Same author

First Measurement of A=4 Hypernuclei and Antihypernuclei at the LHC.

Physical review letters·2025
Same author

Rivastigmine as an alternative treatment for anticholinergic toxidrome in light of the physostigmine shortage: A case series.

The American journal of emergency medicine·2025

Area of Science:

  • Hematology
  • Oncology
  • Clinical Trials

Background:

  • Hodgkin's lymphoma therapy presents significant challenges, particularly for specific patient groups.
  • Current treatment strategies require refinement to address areas of difficulty in managing Hodgkin's lymphoma.
  • The need for improved therapeutic approaches and data collection in Hodgkin's lymphoma is critical.

Purpose of the Study:

  • To explore challenging areas in Hodgkin's lymphoma therapy.
  • To provide evidence for the efficacy of risk-related therapy and web-based data collection programs.
  • To highlight the need for novel salvage regimens and improved treatment evaluation for elderly patients.

Main Methods:

  • Analysis of unpublished data from the UK on risk-based therapy for young Hodgkin's lymphoma patients.
  • Review of an index developed at Memorial Sloan-Kettering Cancer Centre (MSKCC) for salvage therapy.
  • Description of the SHIELD project utilizing on-line registration for a Phase II study of VEPEMB in elderly patients.

Main Results:

  • Risk-based therapy shows improved outcomes in poor-prognosis Hodgkin's lymphoma patients aged 15-19 years.
  • The MSKCC index indicates an urgent need for new second-line regimens for poor-prognosis patients.
  • The SHIELD project is successfully facilitating on-line registration and ethical guidance for elderly patient trials.

Conclusions:

  • Tailored, risk-stratified treatment is essential for both adolescent and adult Hodgkin's lymphoma patients.
  • Elderly Hodgkin's lymphoma patients are underrepresented in clinical trials, necessitating new data pooling strategies.
  • Web-based data collection and risk-based approaches, exemplified by the SHIELD project, can advance Hodgkin's lymphoma treatment.

Related Experiment Videos